Personalized OncoTherapeutics

Personalized OncoTherapeutics appears to have been a private U.S. biotechnology startup focused on developing a scalable, personalized therapeutic cancer vaccine platform. Publicly available information is very limited, but multiple secondary sources identify the company as having conducted early research studies under the leadership of Alexander Gaidamaka. A startup profile lists the company in Athens, Georgia and describes it as concept-stage, while another profile characterizes its technology as a scalable and commercializable personalized therapeutic cancer vaccine approach. There is no evidence that the company advanced into named clinical programs, public markets, or a disclosed acquisition, and it appears to be inactive today.